GlassScriptPhysician profile
Sumit Kaur Johl
NPI 1245314624
$713.24
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.84 · 2020: $30.63 · 2021: $63.26 · 2022: $13.17 · 2023: $179 · 2024: $181 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.25 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Incyte Corporation | $126.10 | 2023 | Jakafi, Monjuvi |
| Glaxosmithkline, LLC. | $99.23 | 2020-2025 | Bexsero, Penmenvy |
| Sanofi Pasteur INC. | $72.35 | 2019-2024 | |
| Alk-Abello, INC | $66.31 | 2024-2025 | Grastek, Odactra |
| Dexcom, INC. | $63.53 | 2024-2025 | Dexcom G6 Transmitter |
| Cranial Technologies, INC | $44.47 | 2023-2024 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $31.99 | 2019 | |
| Sobi, INC | $31.89 | 2021-2022 | |
| Novo Nordisk INC | $23.74 | 2019 | |
| Ironshore Pharmaceuticals INC. | $18.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Johl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.